Catalyst Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 18.63 M | $434.75 M | 2.25% | 15.19% |
| VANGUARD GROUP INC | 01/29/2026 | 8.43 M | $196.81 M | -3.23% | 6.88% |
| STATE STREET CORP | 02/13/2026 | 6.91 M | $161.22 M | 7.84% | 5.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/17/2026 | 4.91 M | $114.63 M | -1.28% | 4.01% |
| FUNDSMITH LLP | 02/17/2026 | 3.36 M | $78.51 M | 0.00% | 2.74% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 3.03 M | $70.61 M | 19.66% | 2.47% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 3.00 M | $69.93 M | 21.89% | 2.44% |
| MORGAN STANLEY | 02/13/2026 | 2.93 M | $68.47 M | 59.11% | 2.39% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.90 M | $67.70 M | 0.35% | 2.37% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 2.65 M | $61.85 M | -25.24% | 2.16% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 2.20 M | $51.34 M | -4.00% | 1.79% |
| ROYCE & ASSOCIATES LP | 02/09/2026 | 1.91 M | $44.60 M | -6.10% | 1.56% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 1.72 M | $40.12 M | 200.55% | 1.40% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 1.62 M | $37.75 M | 23.95% | 1.32% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.36 M | $31.66 M | 1.84% | 1.11% |
| INVESCO LTD. | 02/19/2026 | 1.29 M | $30.19 M | 4.88% | 1.06% |
| BOSTON PARTNERS | 02/13/2026 | 1.23 M | $28.54 M | -4.62% | 1.00% |
| NORTHERN TRUST CORP | 02/17/2026 | 1.21 M | $28.29 M | -4.11% | 0.99% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2026 | 1.21 M | $28.23 M | 14.10% | 0.99% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 993.65 K | $23.19 M | -15.73% | 0.81% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 979.54 K | $22.86 M | -2.75% | 0.80% |
| VICTORY CAPITAL MANAGEMENT INC | 02/13/2026 | 884.61 K | $20.65 M | 111.88% | 0.72% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 841.91 K | $19.62 M | 8.87% | 0.69% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 02/17/2026 | 778.59 K | $18.17 M | 100.00% | 0.64% |
| LEGAL & GENERAL GROUP PLC | 02/09/2026 | 776.17 K | $18.12 M | 0.27% | 0.63% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 748.78 K | $17.48 M | 0.69% | 0.61% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 02/09/2026 | 723.24 K | $16.88 M | 5.48% | 0.59% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 700.66 K | $16.35 M | -0.47% | 0.57% |
| PRINCIPAL FINANCIAL GROUP INC | 02/02/2026 | 683.68 K | $15.96 M | 6.97% | 0.56% |
| FEDERATED HERMES, INC. | 02/12/2026 | 663.75 K | $15.49 M | 70.50% | 0.54% |
| UBS GROUP AG | 01/29/2026 | 648.99 K | $15.15 M | 9.33% | 0.53% |
| GLENMEDE TRUST CO NA | 02/17/2026 | 618.22 K | $14.43 M | 100.00% | 0.50% |
| SWEDBANK AB | 02/09/2026 | 616.13 K | $14.38 M | 0.00% | 0.50% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 02/12/2026 | 594.07 K | $13.87 M | -19.68% | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 02/17/2026 | 586.97 K | $13.70 M | 11.05% | 0.48% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/12/2026 | 567.44 K | $13.24 M | 27.12% | 0.46% |
| LSV ASSET MANAGEMENT | 02/06/2026 | 539.90 K | $12.60 M | -2.26% | 0.44% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 02/13/2026 | 492.94 K | $11.51 M | -4.61% | 0.40% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 487.14 K | $11.37 M | -40.68% | 0.40% |
| GABLES CAPITAL MANAGEMENT INC. | 02/06/2026 | 424.62 K | $9.91 M | -2.48% | 0.35% |
| NUVEEN, LLC | 02/12/2026 | 418.52 K | $9.77 M | -22.81% | 0.34% |
| PACER ADVISORS, INC. | 02/24/2026 | 393.73 K | $9.19 M | -36.58% | 0.32% |
| JUPITER ASSET MANAGEMENT LTD | 02/10/2026 | 390.37 K | $9.11 M | -2.67% | 0.32% |
| JW ASSET MANAGEMENT, LLC | 02/06/2026 | 388.39 K | $9.07 M | 0.00% | 0.32% |
| ABRDN PLC | 01/16/2026 | 387.91 K | $9.05 M | -38.66% | 0.32% |
| JPMORGAN CHASE & CO | 02/11/2026 | 369.84 K | $8.63 M | -2.37% | 0.30% |
| ALLIANZ ASSET MANAGEMENT GMBH | 02/11/2026 | 366.76 K | $8.56 M | -54.04% | 0.30% |
| PRUDENTIAL FINANCIAL INC | 02/13/2026 | 364.82 K | $8.51 M | -9.43% | 0.30% |
| BARCLAYS PLC | 02/13/2026 | 358.18 K | $8.36 M | -3.95% | 0.29% |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 358.17 K | $8.36 M | 2.10% | 0.29% |
Catalyst Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 489 institutional investors and hedge funds held shares of Catalyst Pharmaceuticals Inc. The most heavily invested institutionals were:
DIMENSIONAL FUND ADVISORS LP: 3.43 M
ROYCE & ASSOCIATES LP: 2.09 M
Boston Partners: 1.71 M
UBS Group AG: 986,090
VANGUARD FIDUCIARY TRUST CO: 802,631
Invesco Ltd.: 752,839
84.79% of Catalyst Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 132.58 M shares in the last 24 months. This purchase volume represents approximately $3.29 B in transactions.